| scholarly article | Q13442814 |
| P356 | DOI | 10.1378/CHEST.99.6.1495 |
| P698 | PubMed publication ID | 2036835 |
| P2093 | author name string | Clemmons DR | |
| Friedman M | |||
| Underwood LE | |||
| Pape GS | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| weight gain | Q3403879 | ||
| P304 | page(s) | 1495-1500 | |
| P577 | publication date | 1991-06-01 | |
| P1433 | published in | Chest | Q5093377 |
| P1476 | title | The effect of growth hormone on weight gain and pulmonary function in patients with chronic obstructive lung disease | |
| P478 | volume | 99 |
| Q33701437 | Administration of growth hormone to catabolic patients |
| Q33901722 | An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease |
| Q35197853 | Androgen effects on body composition |
| Q40472387 | Anterior Pituitary Function and Growth Hormone Use in the Elderly |
| Q55287274 | Can muscle protein metabolism be specifically targeted by nutritional support and exercise training in chronic obstructive pulmonary disease? |
| Q35816104 | Clinical actions of growth hormone |
| Q34182382 | Clinical applications of recombinant human growth hormone in adults |
| Q34008364 | Dangers of growth hormone therapy in critically ill patients |
| Q47734308 | Deterioration of Limb Muscle Function During Acute Exacerbation of Chronic Obstructive Pulmonary Disease |
| Q72600312 | Effect of growth hormone and protein intake on tumor growth and host cachexia |
| Q54324848 | Effect of growth hormone in experimental tooth movement. |
| Q41811066 | Effect of growth hormone on human alveolar macrophage oxidative metabolism |
| Q77390770 | Effect of low-dosage recombinant human growth hormone therapy on pulmonary function in hypopituitary patients with adult-onset growth hormone deficiency |
| Q37464686 | Effects of anabolic steroids on chronic obstructive pulmonary disease: a meta-analysis of randomised controlled trials |
| Q33888618 | Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously. |
| Q34106173 | Enhancing physical performance in chronic obstructive pulmonary disease |
| Q39646434 | Expression of growth hormone receptor and its mRNA in hepatic cirrhosis |
| Q73681267 | Growth hormone therapy in intensive care patients: from biochemistry to muscle function |
| Q34182027 | Growth hormone: current and future therapeutic applications |
| Q37133007 | IGF1 and IGFBP3 in acute respiratory distress syndrome |
| Q24200934 | Interventions for preventing critical illness polyneuropathy and critical illness myopathy |
| Q24241368 | Interventions for preventing critical illness polyneuropathy and critical illness myopathy |
| Q24243431 | Interventions for preventing critical illness polyneuropathy and critical illness myopathy |
| Q54548525 | Leucine and glucose kinetics during growth hormone treatment in intrauterine growth-retarded preterm infants. |
| Q33963210 | Meal pattern of male rats maintained on amino acid supplemented diets: the effect of tryptophan, lysine, arginine, proline and threonine |
| Q36726338 | New treatments for chronic obstructive pulmonary disease using ergogenic aids |
| Q41433978 | Nutrition and outcome in chronic respiratory disease |
| Q34149572 | Nutritional abnormalities and supplementation in chronic obstructive pulmonary disease |
| Q79914695 | Nutritional considerations in the treatment of chronic obstructive pulmonary disease |
| Q35019743 | Nutritional interventions for cancer-induced cachexia |
| Q24202330 | Nutritional supplementation for stable chronic obstructive pulmonary disease |
| Q24244188 | Nutritional supplementation for stable chronic obstructive pulmonary disease |
| Q41611564 | Nutritional support in advanced lung disease. The pulmonary cachexia syndrome |
| Q51090073 | Nutritional, respiratory, and psychological effects of recombinant human growth hormone in patients undergoing abdominal aortic aneurysm repair. |
| Q36309971 | Performance enhancement in chronic obstructive pulmonary disease. |
| Q34729747 | Pharmacotherapy and medical complications of eating disorders in children and adolescents |
| Q41293360 | Pharmacotherapy of respiratory muscles in chronic obstructive pulmonary disease |
| Q46574596 | Physical effects of short-term recombinant human growth hormone administration in abstinent steroid dependency |
| Q28570718 | Protective effects of recombinant human growth hormone on cirrhotic rats |
| Q33637756 | Rationale for anabolic therapy to facilitate rehabilitation in chronic obstructive pulmonary disease |
| Q90418842 | Recent Advances in Molecular Basis of Lung Aging and Its Associated Diseases |
| Q74830376 | Recombinant human growth hormone: old and novel uses |
| Q35771480 | Reversal of chronic obstructive pulmonary disease-associated weight loss : are there pharmacological treatment options? |
| Q44698502 | Role of anabolic hormonal factors in surgery in adults |
| Q36028202 | Sarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle mass |
| Q34061404 | Structural and functional changes of peripheral muscles in chronic obstructive pulmonary disease patients |
| Q40670236 | The application of nutritional science to clinical practice |
| Q33721959 | The pulmonary cachexia syndrome: aspects of energy balance |
| Q51569923 | The role of IGFs in catabolism. |
| Q40386601 | The role of insulin, growth hormone and IGF-I as anabolic agents in the critically ill. |
| Q33829486 | Tissue wasting in patients with chronic obstructive pulmonary disease |
| Q40749572 | Unanswered questions concerning the treatment of hyposomatotropism and hypogonadism in elderly men. |
| Q33750201 | Update on clinical trials of growth factors and anabolic steroids in cachexia and wasting |
| Q71181929 | Use of growth hormone for postoperative respiratory failure |
| Q77421156 | [Growth hormone: a magical potion?] |
Search more.